Option Care Health, Inc. (NASDAQ:OPCH) Holdings Raised by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 24,250.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 2,922 shares of the company’s stock after acquiring an additional 2,910 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Option Care Health were worth $98,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. First Horizon Advisors Inc. purchased a new stake in Option Care Health in the 3rd quarter worth approximately $37,000. Headlands Technologies LLC raised its holdings in shares of Option Care Health by 5,796.7% during the 3rd quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock valued at $57,000 after purchasing an additional 1,739 shares in the last quarter. IFP Advisors Inc raised its holdings in shares of Option Care Health by 20,350.0% during the 3rd quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock valued at $79,000 after purchasing an additional 2,442 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Option Care Health by 219.6% during the 3rd quarter. Fifth Third Bancorp now owns 2,723 shares of the company’s stock valued at $88,000 after purchasing an additional 1,871 shares in the last quarter. Finally, International Assets Investment Management LLC raised its holdings in shares of Option Care Health by 1,513.7% during the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock valued at $103,000 after purchasing an additional 2,876 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH opened at $29.29 on Friday. The company has a market capitalization of $5.09 billion, a PE ratio of 19.27, a price-to-earnings-growth ratio of 1.65 and a beta of 1.22. Option Care Health, Inc. has a one year low of $24.23 and a one year high of $35.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.33. The company’s fifty day moving average price is $32.04 and its 200 day moving average price is $31.50.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.22 by $0.04. The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The business’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. As a group, analysts expect that Option Care Health, Inc. will post 1.17 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the stock. Jefferies Financial Group raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a report on Monday, March 4th. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the firm’s stock in a transaction on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the transaction, the director now directly owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.